Iotrolan liposomalAlternative Names: TLC I 16
Latest Information Update: 16 Nov 1998
At a glance
- Originator The Liposome Company
- Class Nonionic contrast media; Triiodobenzoic acids
- Mechanism of Action Emission-computed tomography enhancers
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Liver metastases
Most Recent Events
- 16 Nov 1998 No development reported - Preclinical for Liver metastases diagnosis in USA (unspecified route)
- 04 Sep 1996 Preclinical development for Liver metastases diagnosis in USA (unspecified route)